Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vivani Medical, Inc. - Common Stock (NQ: VANI )

1.180 +0.020 (+1.72%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 9, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 52,753
Open 1.160
Bid (Size) 1.140 (23)
Ask (Size) 1.290 (1)
Prev. Close 1.160
Today's Range 1.160 - 1.190
52wk Range 0.8400 - 7.800
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pineapple Financial And 1 Other Stock Under $1 Insiders Are Buying
Via Benzinga
Vivani Medical And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga

Performance

YTD
+13.46%
+13.46%
1 Month
-5.60%
-5.60%
3 Month
-34.81%
-34.81%
6 Month
+15.69%
+15.69%
1 Year
-0.84%
-0.84%

More News

Read More
Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
From Vivani Medical, Inc.
Via Business Wire
EXCLUSIVE: Vivani Medical Outlines Plans To Kickstart First Clinical Study For Miniature GLP-1 Obesity Implant Program This Year
Via Benzinga
Why Signet Jewelers Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why GLP-1 Developer Vivani Medical's Stock Is Climbing
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Vivani Medical Announces FDA Clears Investigational New Drug Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term Subdermal GLP-1 Drug Implant
From Vivani Medical, Inc.
Via Business Wire
EXCLUSIVE: Vivani Medical's Type 2 Diabetes Treatment NPM-119 Subdermal Implant's NDA Gains FDA Clearance For Clinical Use
Via Benzinga
Exposures Product Safety
Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant
From Vivani Medical, Inc.
Via Business Wire
EXCLUSIVE: Vivani Medical Highlights Weight Loss Data For GLP-1 Implant Supporting Potential Veterinary Use
Via Benzinga
VANI Stock Earnings: Vivani Medical Meets EPS for Q1 2024
Via InvestorPlace
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
From Vivani Medical, Inc.
Via Business Wire
Vivani Medical to Present at TIDES Conference 2024
From Vivani Medical, Inc.
Via Business Wire
VANI Stock Earnings: Vivani Medical Beats EPS for Q4 2023
Via InvestorPlace
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
From Vivani Medical, Inc.
Via Business Wire
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
From Vivani Medical, Inc.
Via Business Wire
Vivani Medical Surges on its Ozempic-Like Weight-Loss Implant
Via MarketBeat
Exposures Product Safety
Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why Zscaler Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
From Vivani Medical, Inc.
Via Business Wire
S&P 500 Edges Lower; ADT Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.